Literature DB >> 28641789

Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.

Stergios A Polyzos1, Christos S Mantzoros2.   

Abstract

Keywords:  adipokine; adipose tissue; familial partial lipodystrophy; leptin; lipodystrophy; metreleptin

Mesh：

Substances：

Year:  2017        PMID： 28641789     DOI： 10.1016/j.metabol.2017.06.003

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  4 in total

Review 1.  GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans.

Authors:  Aimilia Eirini Papathanasiou; Eric Nolen-Doerr; Olivia M Farr; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2019-02-01       Impact factor: 6.664

2.  Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study.

Authors:  Baris Akinci; Elif A Oral; Adam Neidert; Diana Rus; Wendy Y Cheng; Philippe Thompson-Leduc; Hoi Ching Cheung; Pamela Bradt; Maria Cristina Foss de Freitas; Renan Magalhães Montenegro; Virgínia Oliveira Fernandes; Elaine Cochran; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 3.  When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD.

Authors:  Alba Rojano-Toimil; Jesús Rivera-Esteban; Ramiro Manzano-Nuñez; Juan Bañares; David Martinez Selva; Pablo Gabriel-Medina; Roser Ferrer; Juan M Pericàs; Andreea Ciudin
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

Review 4.  Lipodystrophies-Disorders of the Fatty Tissue.

Authors:  Birgit Knebel; Dirk Müller-Wieland; Jorg Kotzka
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.